Plasma and Antibody Glycomic Biomarkers of Time to HIV Rebound and Viral Setpoint

OBJECTIVE: HIV cure research urgently needs to identify pre-Analytic Treatment Interruption (ATI) biomarkers of time-to-viral-rebound and viral setpoint to mitigate the risk of ATI and accelerate development of a cure. We previously reported that galactosylated IgG glycans, G2, negatively correlate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:AIDS
Egile Nagusiak: GIRON, Leila B, PAPASAVVAS, Emmanouil, AZZONI, Livio, YIN, Xiangfan, ANZUREZ, Alitzel, DAMRA, Mohammad, MOUNZER, Karam, KOSTMAN, Jay R., SANNE, Ian, FIRNHABER, Cynthia S., TATENO, Hiroaki, LIU, Qin, MONTANER, Luis J, ABDEL-MOHSEN, Mohamed
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072000/
https://ncbi.nlm.nih.gov/pubmed/31972605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002476
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak